Please login to the form below
Editing
This page shows the latest Editing news and features for those working in and with pharma, biotech and healthcare.
Moderna and Life Edit partner to accelerate gene editing therapies
editing technologies as part of our broader research and development engine, helping to advance our mission and deliver on the promise of mRNA.". ... Our novel editing systems have the potential to precisely modify gene targets for both in vivo and ex
Latest news
-
New T-cell study demonstrates ‘powerful’ potential for tailored cancer medicine
The results were published in a peer-reviewed paper in Nature. Patients diagnosed with untreatable cancers have been involved in a new experimental study exploring the potential of gene editing technology ... short palindromic repeats (CRISPR) technology,
-
ICR study raises possibility of predicting drug resistance in advance
The study, published in the journal Cancer Research, involved the use of the gene editing technology CRISPR to break or switch off each of 25, 000 genes in cancer cells treated
-
Genentech and ArsenalBio join to identify successful T-cell oncology therapies
ArsenalBio’s engineering platform spans a range of cutting-edge technology, including high-throughput CRISPR-based gene editing, synthetic biology and computational biology, to create new synthetic biological programmes aimed at
-
Novartis and Precision BioSciences announce in vivo gene editing collaboration
Novartis and Precision BioSciences (Precision) have announced an in vivo gene editing research and development collaboration to develop potentially curative treatments for disorders including sickle cell disease (SCD) and beta thalassaemia.
-
AstraZeneca officially opens new R&D facility in UK
said. The Discovery Centre will support AstraZeneca’s focus on specialised and precision medicines and foster the discovery and development of next-generation therapeutics, including nucleotide-based, gene-editing and cell
More from news
Approximately 11 fully matching, plus 76 partially matching documents found.
Latest Intelligence
-
How early-stage clinical research is facilitating the new wave of personalised medicines
Lastly, gene editing is a hugely promising area for new drug development in which DNA is inserted, deleted, modified or replaced in a genome. ... This type of technology is becoming a reality for diseases where a genetic defect is known and appropriate
-
Switzerland: a life sciences hub
cells engineered to display chimeric antigen receptors) and genome editing (ie, CRISPR/Cas, TALEN, ZNF).
-
Risks, reforms and rewards: the evolving Russian healthcare market
The aim of the programme is to ‘to implement a comprehensive solution to the task of the accelerated development of genetic technologies, including genetic editing, and to establish scientific and technological
-
Alzheimer’s: the search for a cure
gene-editing specialist Sangamo for rights to tau-targeting drug ST-501 as part of a broader R&D alliance.
-
Novo Nordisk awakens its ‘Sleeping Beauty’
The next phases were to enrich the pipeline with acquisitions and partnerships, including a headline deal with blue-bird bio for next generation gene editing that could lead to a potential ... We also have a stem cell platform, gene editing, an exquisite
More from intelligence
Approximately 2 fully matching, plus 24 partially matching documents found.
Latest appointments
-
Syneos Health Communications announces senior hires to Europe-based team
Jenny Fanstone (pictured right), who joins as scientific director, brings over 20 years of experience in medical writing, strategic communication, publication planning and medical editing team to the Syneos team.
-
Editas Medicine names James Mullen as chairman
He has previously served as CEO of Patheon. Genome editing company Editas Medicine has appointed James Mullen as chairman of the board of directors.
-
Box Bear expands its creative offering
Jordan Alexander, who joins the Berkshire-based agency from PMN Group, brings two years’ experience in animation, green screen compositing, video editing and special effects.
-
Editas Medicine adds to its board of directors
Jessica Hopfield will also serve on the genome editing firm's audit committee. ... Genome editing company Editas Medicine has strengthened its board of directors with the addition of Jessica Hopfield, who will also serve on the board's audit committee.
-
Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel
They will join the board of directors. Genome editing group Intellia Therapeutics has appointed Moncef Slaoui and Frank Verwiel to join its board of directors at a time when the board ... We look forward to their guidance as we continue to advance our
More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
A Magical Future – A year on from the graduate scheme
We were introduced to strategic brand planning, editing, account management, medical writing and much more.
-
Declan Rice features in new campaign for suicide prevention charity Campaign Against Living Miserably
The project wouldn’t have been possible without the support of Entourage Sports &Entertainment, Trim Editing, ETC, The Hotspring, Factory Studios, and many others.
-
The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia
Several manufacturers are developing novel treatments for the disease, including Vertex, which has partnered with CRISPR Therapeutics to develop a gene-editing treatment for beta-thalassemia and sickle cell. ... The move marks a continuation in its
-
Why project managers are key to creating quality content
Rachel is Editorial Production Manager at Thrive. She is responsible for coordinating projects as well as editing and delivering engaging health content.
-
5 steps to health content accreditation success
Rachel is Editorial Production Manager at Thrive. She is responsible for coordinating projects as well as editing and delivering engaging health content.
More from PMHub
Approximately 5 fully matching, plus 38 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Roche’s Polivy backed by FDA Advisory Committee for lymphoma therapy
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- LEO Pharma enters clinical trial partnership with ICON
- Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- UCB's bimekizumab shows continued improvement in hidradenitis suppurativa patients
- The Considered appoints Bam Zahraie as chief experience officer
- The impact of pharma congresses on HCPs – virtual and in person
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
- A relentless commitment to neuroscience
- Putting the ovation into innovation: trends from ESMO
- Sanofi to acquire Provention Bio in deal worth $2.9bn
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
nzyme
The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...
Latest intelligence
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
- WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
- By offering patients knowledge, skills and confidence, they empower patients to be more actively involved in their health. Holistic support can help tackle adherence, mental health or anything else patients...
